Oliceridine inhibits the ED50 of pain during emergence from intravenous remifentanil combined anesthesia in LC: a prospective sequential study

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400083033

Enrollment

Unknown

Registered

2024-04-15

Start date

2024-05-01

Completion date

Unknown

Last updated

2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

The Oliceridine group:Sequential doses of oliceridine were given

The control group:The same volume of normal saline was given

Eligibility

Sex/Gender

All

Age

25 Years to 60 Years

Inclusion criteria

Inclusion criteria: The patients were of American Society of Anesthesiologists physical status ? or ?, aged 25-60 yr, with body mass index <30kg/cm2

Exclusion criteria

Exclusion criteria: Patients with abnormal liver and kidney function before operation, a history of cardiovascular and respiratory diseases, and a history of long-term use of sedative and analgesic drugs

Design outcomes

Primary

Measure	Time frame
Pain score;	—

Secondary

Measure	Time frame
Postoperative extubation time;Nausea and vomiting;Rescue analgesic doses;Respiratory depression;Pruritus;	—

Countries

China

Contacts

Public ContactCao Xianghua

Dongguan Tungwah Hospital, Dongguan, China

18205188357@163.com+86 136 5026 6518

Outcome results